First-in-human dose-escalation study of NBF-006, a novel investigational siRNA targeting GSTP, in patients with non-small cell lung, pancreatic, or colorectal cancer.

Anthony W. Tolcher, Sonya Zabludoff, John Nemunaitis et al.|Journal of Clinical Oncology|2023

Cited by 13